Emerging Research

Treatment for Newly Diagnosed Hodgkin Lymphoma

Hodgkin lymphoma expert Dr. Sairah Ahmed joins Esther Schorr to talk about newly diagnosed patients and the opportunities they have for treatment options and clinical trials.

Sairah Ahmed, MD, Esther Schorr

Will Hodgkin Lymphoma Patients Benefit From Checkpoint Inhibitors?

Do checkpoint inhibitors have a role in Hodgkin lymphoma care as a frontline treatment? Watach as Dr. Andrew Evens and Dr. Joshua Brody discuss the latest research developments, immunotherapy and more.